[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Page 51341]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19915]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-39-2021]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts; Authorization 
of Proposed Production Activity; Wyeth Pharmaceuticals, LLC (mRNA Bulk 
Drug Substance); Andover, Massachusetts

    On May 13, 2021, Wyeth Pharmaceuticals, LLC (Wyeth) submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 27R, in Andover, Massachusetts.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 27067, May 19, 2021). On 
September 10, 2021, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: September 10, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-19915 Filed 9-14-21; 8:45 am]
BILLING CODE 3510-DS-P